Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metofid TM 40mg/25mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Fidelity Lifesciences Pvt Ltd

Salt Composition

Telmisartan (40mg) + Metoprolol Succinate (25mg)

Overview Metofid TM 40mg/25mg Tablet ER

Cardiovasc-Guard ER 40mg/25mg tablets manage hypertension, reducing the risk of cardiovascular events like strokes and heart attacks. Early intervention improves survival rates following a heart attack. Take Cardiovasc-Guard ER with food daily at the same time for consistent blood levels; continue as directed by your physician. Do not discontinue without consulting your doctor, as hypertension is often asymptomatic. Lifestyle modifications, including regular exercise, weight management, and a healthy diet, further support blood pressure control. Follow your doctor's instructions carefully. Potential side effects include headache, weakness, lightheadedness, low blood pressure, elevated potassium, occasional orthostatic hypotension (possibly with fainting), shortness of breath, nausea, vomiting, stomach pain, and tiredness. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly from a seated position. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be required. Inform your doctor of any kidney or liver issues before starting treatment. Pregnant or breastfeeding individuals should consult their physician before use. Disclose all other medications, especially those for hypertension or heart conditions.

Uses of Metofid TM 40mg/25mg Tablet ER

Managing Elevated Blood Pressure

Major Benefits of Metofid TM 40mg/25mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; avoid chewing, crushing, or breaking it. Consume Metofid TM 40mg/25mg Extended-Release Tablets with food.

Common Side effects of Metofid TM 40mg/25mg Tablet ER:

  • Headache
  • Weakness
  • Dizziness
  • Cold extremities
  • Slow heart rate
  • Increased potassium level in blood
  • Decreased blood pressure
  • Orthostatic hypotension (sudden lowering of blood pressure on standing)
  • Breathlessness
  • Vomiting
  • Abdominal pain

How to use Metofid TM 40mg/25mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. The Metofid TM 40mg/25mg Extended-Release tablet should be taken with a meal.

How Metofid TM 40mg/25mg Tablet ER works:

Telmisartan and Metoprolol Succinate, combined in Metofid™ ER 40mg/25mg tablets, provide a dual-action approach to hypertension management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Metofid TM 40mg/25mg Extended-Release tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Metofid TM 40mg/25mg tablets pose a confirmed risk to a developing fetus and should not be used during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Metofid TM 40mg/25mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with this medication.

DrivingDrivingUNSAFE

Extended-release Metofid™ 40mg/25mg tablets can reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Metofid™ 40mg/25mg extended-release tablets are considered safe for use in individuals with impaired renal function. No alteration of the Metofid™ 40mg/25mg extended-release tablet dosage is advised.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when using Metofid TM 40mg/25mg Extended-Release tablets. Dosage modification of Metofid TM 40mg/25mg Extended-Release tablets may be necessary. Physician consultation is advised.

What if you forget to take Metofid TM 40mg/25mg Tablet ER :

Should you forget a Metofid TM 40mg/25mg Extended-Release Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metofid TM 40mg/25mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Heart

FAQs on Metofid TM 40mg/25mg Tablet ER

Dizziness is a possible side effect of Metofid™ 40mg/25mg Tablet ER Succinate, particularly when standing up quickly after sitting or lying down. To minimize this risk, stand slowly.
Enhance your health by adopting a healthier lifestyle alongside Metofid™ 40mg/25mg Tablet ER Succinate. Quitting smoking significantly reduces your risk of heart attack and stroke. Weight management, through diet and exercise, is crucial if you're overweight or obese. A balanced diet rich in fruits and vegetables, combined with regular physical activity, strengthens your heart and lowers heart attack risk.
Continue taking your Metofid TM 40mg/25mg Extended-Release tablets as prescribed, even if you feel better. Abruptly stopping this medication can cause serious health problems, including heart attack and stroke.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Metofid TM 40mg/25mg Tabl...
69
MRP 80
13% off